… Last, we assessed combinations of monoclonal antibodies and found several, … antibody
combinations that can be used for treatment and have demonstrated how these combinations …

… use of an antibody combination that could … SARS-CoV-2 variants of concern. This work
provides evidence for developing a combination of antibodies as prophylaxis against SARS-CoV-…

… -Hu-1 SARS-CoV-2 spike protein (183 and 94 antibodies isolated from AZ/… Memory B cell
antibodies elicited by mRNA, Ad26.… antibodies and RBD, we imaged WT Wuhan-Hu-1 SARS-…

… introduced antibody and vaccine countermeasures. Here, using monoclonal antibodies (…
, we report the impact on antibody neutralization of a panel of authentic SARS-CoV-2 variants …

… coronavirus 2 (SARS-CoV-2) is currently the biggest healthcare issue worldwide. This study
aimed to develop a monoclonal antibody against SARS-CoV… human monoclonal antibodies (…

… These MAb therapeutics are solely targeting the receptor-binding domain of the SARS-CoV-2 …
We report that a combination of two neutralizing antibodies targeting the receptor-binding …

… SARS-CoV-2 Omicron lineage strains (BA.1, BA.1.1, and BA.2) of two monoclonal antibody
… AZD7442 [AstraZeneca] combination), which correspond to ones used to treat or prevent …

… antibodies are a promising therapy. A noncompeting pair of human neutralizing antibodies
(B38 and H4) blocking SARS-CoV-… antibodies, antibody combinations and bsAb using SARS-…

… -19 prevention, neutralizing monoclonal antibodies (mAbs), … severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2)… As prevalence of SARS-CoV-2 variants can differ by country …

… A broad range of both novel and repurposed therapies have been evaluated as potential
treatments for SARS-CoV-2 infection, to be used in combination with supportive care measures…